Global Retirement Partners’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History

Global Retirement Partners’s Portfolio KLDO Stock Details KLDO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-265	Closed	–	–	2963
2022 Q1	$0	Buy	+265	New	+$473	﹤0.01%	2848
2021 Q4	–	Sell	-265	Closed	-$1K	–	2008
2021 Q3	$1K	Hold	265	–	–	﹤0.01%	1968
2021 Q2	$2K	Hold	265	–	–	﹤0.01%	1773
2021 Q1	$2K	Hold	265	–	–	﹤0.01%	1688
2020 Q4	$2K	Buy	+265	New	+$2.17K	﹤0.01%	1648

Other funds holding KLDO

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Global Retirement Partners's KLDO Position: Q2 2022 in Review

Global Retirement Partners sold out of Kaleido Biosciences, Inc. Common Stock (KLDO) in Q2 2022, closing a stake of 265 shares.

Global Retirement Partners first reported a position in KLDO in Q4 2020 and held it in 5 quarters. The position peaked at $2K in Q2 2021. 3 funds tracked by Wall St. Rank hold KLDO as of Q2 2022.

Global Retirement Partners reported no remaining Kaleido Biosciences, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Global Retirement Partners sold 265 Kaleido Biosciences, Inc. Common Stock shares in Q2 2022.
Global Retirement Partners first reported a position in Kaleido Biosciences, Inc. Common Stock in Q4 2020 and held it in 5 quarters.
Global Retirement Partners's Kaleido Biosciences, Inc. Common Stock position peaked at $2K in Q2 2021.
3 funds tracked by Wall St. Rank held Kaleido Biosciences, Inc. Common Stock as of Q2 2022.

Based on Global Retirement Partners's 13F filing for Q2 2022, filed 15 Jul 2022.